Alta Life Sciences

Investor type

VC

Founded

2016

AUM

$85 M

Location

Barcelona, Barcelona, Spain

Investment Ticket

$1-5 m

Investment Stage

Seed Series A

Region of investment

North America Europe
Investor profile last updated: 16 August, 2026

Profile

Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.

Alta LS is a bridge fund, connecting both sides of the Atlantic, joining the Spanish life sciences ecosystem with the Venture Capital expertise of Silicon Valley.

The management team, led by Guy Nohra*, is headquartered in Barcelona. The remainder of the team is formed by experienced life science professionals from the US and Spain.

*Mr. Nohra is co-founder of Alta Partners, a leading pioneer Venture Capital firm in life sciences, funding over 150 companies since 1996. He was named to the 2007 Forbes Midas List of dealmakers in Venture Capital.

Altamar Private Equity, SGIIC, SAU is the Fund’s Management Company.

Industry

Fashion/Beauty Healthcare Services Software HealthTech Biotechnology Medical Devices MedTech Life Sciences Digital AI Technology

Alta Life Sciences Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Alta Life Sciences Spain I FCR
Venture Capital (VC)
Biotechnology
Digital
Medical Devices
AI
Technology
Life Sciences
HealthTech
Pre-seed
Seed
Series A
Europe
$5-10 m
$85 M
September 2016

Contacts

Name
Title
Email
avatar
Miguel Valls Founding Partner
Founding Partner
m•••@•••
avatar
Jose Mesa Partner
Partner
j•••@•••
Upgrade to see contacts
avatar
bHl4vMRAT0U7r8id bHl4vMRAT0U7r8id
bHl4vMRAT0U7r8id
avatar
bHl4vMRAT0U7r8id bHl4vMRAT0U7r8id
bHl4vMRAT0U7r8id
avatar
bHl4vMRAT0U7r8id bHl4vMRAT0U7r8id
bHl4vMRAT0U7r8id
Investment-team contacts for Alta Life Sciences — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Alta Life Sciences

Alta Life Sciences is a venture capital firm. It backs companies at Seed and Series A, writing tickets of $1-5 m.
Alta Life Sciences is located in Barcelona, Barcelona, Spain.
Alta Life Sciences was founded in 2016.
Alta Life Sciences invests in companies and startups in Fashion/Beauty, Healthcare Services, Software, HealthTech, Biotechnology, Medical Devices, MedTech, Life Sciences, Digital, AI, Technology.
Alta Life Sciences invests in companies and startups in North America, Europe.
Alta Life Sciences invests in companies and startups at Seed, Series A.
Alta Life Sciences usually invests $1-5 m on average.
Alta Life Sciences has around $85m assets under management.
Alta Life Sciences last fund was created/launched in 2016-09-23
Alta Life Sciences can be reached through its website altals.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Alta Life Sciences — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Alta Life Sciences directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.